TCI Wealth Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-227
Closed -$11K 1710
2023
Q1
$11K Sell
227
-36
-14% -$1.9K ﹤0.01% 1028
2022
Q4
$15.8K Buy
263
+36
+16% +$2.11K ﹤0.01% 807
2022
Q3
$14K Buy
227
+1
+0.4% +$32 ﹤0.01% 837
2022
Q2
$6K Buy
226
+88
+64% +$2.57K ﹤0.01% 1387
2022
Q1
$5K Sell
138
-22
-14% -$793 ﹤0.01% 1581
2021
Q4
$8K Buy
160
+43
+37% +$2.38K ﹤0.01% 1353
2021
Q3
$8K Buy
117
+23
+24% +$1.43K ﹤0.01% 1281
2021
Q2
$5K Buy
+94
New +$2.93K ﹤0.01% 1472

Other funds holding PRTA

TCI Wealth Advisors's PRTA Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Prothena Corp (PRTA) in Q2 2023, closing a stake of 227 shares — an estimated $11K sold.

TCI Wealth Advisors first reported a position in PRTA in Q2 2021 and held it in 8 quarters. The position peaked at $15.8K in Q4 2022. 196 funds tracked by Wall St. Rank hold PRTA as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Prothena Corp position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 227 Prothena Corp shares in Q2 2023, an estimated $11K.
  • TCI Wealth Advisors first reported a position in Prothena Corp in Q2 2021 and held it in 8 quarters.
  • TCI Wealth Advisors's Prothena Corp position peaked at $15.8K in Q4 2022.
  • 196 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.